neoadjuvant chemotherapy
Showing 9951 - 9975 of >10,000
Esophageal Cancer, Gastric Cancer Trial in United States (Regorafenib, 5-Fluorouracil, Leucovorin)
Completed
- Esophageal Cancer
- Gastric Cancer
- Regorafenib
- +3 more
-
Basking Ridge, New Jersey
- +4 more
May 1, 2020
Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)
Completed
- Squamous Cell Carcinoma of Head and Neck
- NDURE
-
Charleston, South CarolinaMedical University of South Carolina
Feb 25, 2021
Cardiotoxicity Trial in Winnipeg (Flax "milk", Oat fibre "milk")
Recruiting
- Cardiotoxicity
- Flax "milk"
- Oat fibre "milk"
-
Winnipeg, Manitoba, CanadaSt. Boniface Albrechtsen Research Centre
Nov 11, 2020
Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IV NSCLC Trial in Los Angeles (Hsp90 inhibitor AUY922, pemetrexed disodium,
Completed
- Recurrent Non-small Cell Lung Cancer
- +2 more
- Hsp90 inhibitor AUY922
- +3 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 1, 2020
Leukemia, Lymphoma Trial in Seattle (rituximab, fludarabine phosphate, pixantrone dimaleate)
Withdrawn
- Leukemia
- Lymphoma
- rituximab
- +2 more
-
Seattle, WashingtonCell Therapeutics, Incorporated
Oct 14, 2020
Breast Cancer Female Trial (Physical exercise)
Completed
- Breast Cancer Female
- Physical exercise
- (no location specified)
Apr 12, 2020
Head and Neck Squamous Cell Carcinoma, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Margin Assessment
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 30, 2021
Leukemia, Myeloid, Acute Trial in United States (PNK-007, Cyclophosphamide, Fludarabine)
Terminated
- Leukemia, Myeloid, Acute
- PNK-007
- +3 more
-
Boston, Massachusetts
- +6 more
Jul 20, 2020
Non Hodgkin Lymphoma, Breast Cancer Trial in Germany (On-body injector, Pre-filled syringe)
Completed
- Non Hodgkin Lymphoma
- Breast Cancer
- On-body injector
- Pre-filled syringe
-
Aschaffenburg, Germany
- +47 more
Dec 16, 2019
Mammary Tumor, Human, Periodontal Diseases, Chemo Effect Trial (Non surgical periodontal Treatment)
Completed
- Mammary Neoplasm, Human
- +2 more
- Non surgical periodontal Treatment
- (no location specified)
Jun 18, 2020
Extranodal NK-T-Cell Lymphoma, Nasal Type Trial in Shanghai, Urumqi (MEDA, Auto-HSCT)
Completed
- Extranodal NK-T-Cell Lymphoma, Nasal Type
- MEDA
- Auto-HSCT
-
Shanghai, Shanghai, China
- +6 more
Apr 24, 2020
Gastric Cancer Trial in Canada, United States (S-1/Cisplatin, 5-FU/cisplatin)
Completed
- Gastric Cancer
-
Huntsville, Alabama
- +32 more
Aug 4, 2020
Peripheral Neuropathy Trial in Shanghai (Compression gloves)
Unknown status
- Peripheral Neuropathy
- Compression gloves
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 24, 2020
Pancreatic Cancer, Locally Advanced Pancreatic Caner Trial in Shanghai (Irreversible electroporation)
Unknown status
- Pancreatic Cancer
- Locally Advanced Pancreatic Caner
- Irreversible electroporation
-
Shanghai, Shanghai, ChinaRenJiH
Mar 13, 2020
Retinoblastoma Trial in Cincinnati (Intra-Ophthalmic Artery Topotecan Infusion)
Terminated
- Retinoblastoma
- Intra-Ophthalmic Artery Topotecan Infusion
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 10, 2020
Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)
CTCs in HNSCC Patients Underwent Curative CCRT
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Circulating Tumor Cell
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Aug 17, 2021
Small Cell Lung Cancer Trial in Seoul (Durvalumab)
Unknown status
- Small Cell Lung Cancer
-
Seoul, MA, Korea, Republic ofSamsung Medical Center
Feb 27, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Pancreatic Cancer, NSCLC, Esophagogastric Cancer Trial in United States (Andecaliximab, Gemcitabine, Nab-paclitaxel)
Completed
- Pancreatic Cancer
- +4 more
- Andecaliximab
- +10 more
-
Birmingham, Alabama
- +17 more
May 20, 2020